ARCA Logo - JPEG.jpg
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
August 23, 2024 16:30 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 23, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced that its Board of Directors (the “Board”) has approved a reverse stock split of...
ARCA Logo - JPEG.jpg
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
April 25, 2024 16:15 ET | ARCA biopharma, Inc.
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA Logo - JPEG.jpg
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
April 03, 2024 07:30 ET | ARCA biopharma, Inc.
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company...
ARCA Logo - JPEG.jpg
ARCA biopharma Announces Second Quarter 2023 Financial Results
July 21, 2023 16:25 ET | ARCA biopharma, Inc.
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE...